Back

Aspirin’s echo: rebound, delay, or statistical mirage? Re-examining legacy cardiovascular risk after cessation

European Heart Journal

18 November 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS CARDIOVASCULAR PHARMACOLOGY

Contributors

Hongxuan Fan
Hongxuan Fan

Author

Boda Zhou
Boda Zhou

Author

You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Congress Presentation
Medical treatment works! Contemporary implementation into clinical practice
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources